Skip To Content

News & Events: Registered Directs


  • April 22 2010

    Registered direct offerings aren't the normal way issuers raise equity capital, but don't mention that to Aeterna Zentaris Inc., which defines itself as "a late-stage drug development company specialized in oncology and endocrine therapy."

  • April 20 2010

    announced today that the Company has entered into a definitive agreement with institutional investors in a registered direct offering of its common stock with gross proceeds of approximately $10.5 million. Hyperdynamics Corporation plans to use the net proceeds from the offering to fund a portion of their 3D seismic data acquisition and processing, certain short…

  • April 20 2010

    announced that it has entered into a definitive securities purchase agreement with a group of select institutional investors to
    purchase US$10 million of its securities in a registered direct offering. No placement agent was utilized in connection with the offering…

  • April 19 2010

    announced today the pricing of a $295 million registered direct offering of common stock to a group of institutional investors. The Company has entered into subscription agreements with the investors to sell an aggregate 58.3 million shares of American Capital's common stock, including 43.725 million shares to funds and accounts…

  • April 17 2010

    AEterna Zentaris, a Canadian drug development company, has received commitments from institutional investors to purchase $15 million of securities in a registered direct offering.

  • April 12 2010

    Proceeds from the registered direct offering will be used for general corporate purposes, including working capital to fund eDiets' future growth opportunities, such as the expansion of advertising related to its fresh-prepared meal delivery service.

  • April 06 2010

    Net proceeds from this offering will be used to drill a horizontal injector well to evaluate Steam Assisted Gravity Drainage (SAGD) at its Pleasant Valley heavy oil project at Oxnard, California, for future use in the development and production of heavy oil reserves.

  • April 01 2010

    Xenonics Holdings, Inc. (NYSE AMEX:XNN), a leading manufacturer of illumination systems for the military and safety agencies, today announced it has entered into definitive agreements with institutional investors to sell 2,900,000 shares of its common stock at a price per share of $0.50, pursuant to a registered direct offering.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”